← Back to Search

Probiotic

Goodbelly for Peripheral Vascular Disease

N/A
Waitlist Available
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diabetes mellitus (Type 1 or Type 2)
Cardiovascular disease.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 24 hours after consumption and approximately 7 days after consumption
Awards & highlights

Study Summary

This trial is testing whether a drug that improves FMD can also reduce the risk of cardiovascular disease.

Eligible Conditions
  • Peripheral Vascular Disease
  • High Cholesterol
  • Cerebral Artery Disease
  • High Blood Pressure
  • Coronary Artery Disease

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have heart problems.
Select...
You must have at least one of the following conditions:
Select...
You have a condition that affects the blood vessels outside your heart and brain.
Select...
You have had a stroke or other diseases related to blood vessels in your brain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 24 hours after consumption and approximately 7 days after consumption
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to 24 hours after consumption and approximately 7 days after consumption for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
change in baseline flow mediated dilation (FMD) after probiotic consumption
Secondary outcome measures
Interleukin-12
Interleukin-6
Interleukin-8

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: GoodBelly ProbioticExperimental Treatment1 Intervention
Subjects randomized to this arm consume one serving of the Goodbelly lactobacillus plantarum 299v probiotic
Group II: PlaceboPlacebo Group1 Intervention
Subjects randomized to this arm consume one serving of the Goodbelly that does not contain lactobacillus plantarum 299v
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Goodbelly
2020
N/A
~30

Find a Location

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
608 Previous Clinical Trials
1,162,471 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for me to become a participant in this clinical trial?

"For this trial, 26 persons age 21-89 who are currently afflicted with cerebral artery disorders and other related conditions (i.e., hypertension, hyperlipidemia, cardiovascular disease) can participate."

Answered by AI

Is the recruitment period open for participants of this clinical trial?

"This clinical trial, initially posted on August 17th 2020 and last updated on October 11th 2022 is no longer actively recruiting patients. However, there are still 1580 other studies that require participants at this time."

Answered by AI

Is mature consent permissible for this endeavor?

"Individuals aged 21 to 89 years old may be recruited for this medical study."

Answered by AI
~6 spots leftby Apr 2025